Boston Scientific Corp (BSX) stock
BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3048% below fair value
$43.03−0.66 (-1.51%)
Close on Nov 17, 2026Market cap $62.36BP/E 17.4Yield –
Boston Scientific operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Boston Scientific's operating cash flow for the twelve months ending Jun 30, 2026 was $4.53B, up 5.7% year over year. For fiscal 2025 it was $4.53B, up 32.0% from the year before. Over ten years it grew 20.7% a year on average. The highest annual figure on record is $4.53B in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.53B | +32.0% |
| FY2024 | Dec 31, 2024 | $3.44B | +37.2% |
| FY2023 | Dec 31, 2023 | $2.50B | +64.0% |
| FY2022 | Dec 31, 2022 | $1.53B | -18.4% |
| FY2021 | Dec 31, 2021 | $1.87B | +24.0% |
| FY2020 | Dec 31, 2020 | $1.51B | -17.9% |
| FY2019 | Dec 31, 2019 | $1.84B | +492.3% |
| FY2018 | Dec 31, 2018 | $310.00M | -78.3% |
| FY2017 | Dec 31, 2017 | $1.43B | +20.6% |
| FY2016 | Dec 31, 2016 | $1.18B | +71.1% |
| FY2015 | Dec 31, 2015 | $691.00M | -45.5% |
| FY2014 | Dec 31, 2014 | $1.27B | +14.3% |
| FY2013 | Dec 31, 2013 | $1.11B | -13.3% |
| FY2012 | Dec 31, 2012 | $1.28B | +27.0% |
| FY2011 | Dec 31, 2011 | $1.01B | +210.2% |
| FY2010 | Dec 31, 2010 | $325.00M | -61.1% |
| FY2009 | Dec 31, 2009 | $835.00M | -31.3% |
| FY2008 | Dec 31, 2008 | $1.22B | +30.2% |
| FY2007 | Dec 31, 2007 | $934.00M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.47B | +14.6% |
| Q1 FY2026 | Mar 31, 2026 | $348.00M | -35.7% |
| Q4 FY2025 | Dec 31, 2025 | $1.36B | -6.3% |
| Q3 FY2025 | Sep 30, 2025 | $1.34B | +34.0% |
| Q2 FY2025 | Jun 30, 2025 | $1.29B | +58.2% |
| Q1 FY2025 | Mar 31, 2025 | $541.00M | +229.9% |
| Q4 FY2024 | Dec 31, 2024 | $1.46B | +52.1% |
| Q3 FY2024 | Sep 30, 2024 | $1.00B | +43.6% |
| Q2 FY2024 | Jun 30, 2024 | $813.00M | +23.6% |
| Q1 FY2024 | Mar 31, 2024 | $164.00M | -13.7% |
| Q4 FY2023 | Dec 31, 2023 | $957.00M | +18.6% |
| Q3 FY2023 | Sep 30, 2023 | $698.00M | +48.5% |
| Q2 FY2023 | Jun 30, 2023 | $658.00M | +114.3% |
| Q1 FY2023 | Mar 31, 2023 | $190.00M | – |
| Q4 FY2022 | Dec 31, 2022 | $807.00M | +68.8% |
| Q3 FY2022 | Sep 30, 2022 | $470.00M | +1.1% |
| Q2 FY2022 | Jun 30, 2022 | $307.00M | -52.3% |
| Q1 FY2022 | Mar 31, 2022 | -$58.00M | -120.4% |
| Q4 FY2021 | Dec 31, 2021 | $478.00M | -29.0% |
| Q3 FY2021 | Sep 30, 2021 | $465.00M | -27.7% |
| Q2 FY2021 | Jun 30, 2021 | $643.00M | +139.0% |
| Q1 FY2021 | Mar 31, 2021 | $284.00M | – |
| Q4 FY2020 | Dec 31, 2020 | $673.00M | -2.7% |
| Q3 FY2020 | Sep 30, 2020 | $643.00M | +28.1% |
| Q2 FY2020 | Jun 30, 2020 | $269.00M | -7.9% |
| Q1 FY2020 | Mar 31, 2020 | -$77.00M | -122.0% |
| Q4 FY2019 | Dec 31, 2019 | $692.00M | +3542.1% |
| Q3 FY2019 | Sep 30, 2019 | $502.00M | +0.2% |
| Q2 FY2019 | Jun 30, 2019 | $292.00M | – |
| Q1 FY2019 | Mar 31, 2019 | $350.00M | +81.3% |
| Q4 FY2018 | Dec 31, 2018 | $19.00M | -97.2% |
| Q3 FY2018 | Sep 30, 2018 | $501.00M | +10.8% |
| Q2 FY2018 | Jun 30, 2018 | -$403.00M | -235.7% |
| Q1 FY2018 | Mar 31, 2018 | $193.00M | – |
| Q4 FY2017 | Dec 31, 2017 | $684.00M | +1.2% |
| Q3 FY2017 | Sep 30, 2017 | $452.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $297.00M | – |
| Q1 FY2017 | Mar 31, 2017 | -$7.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $676.00M | – |
| Q3 FY2016 | Sep 30, 2016 | -$31.00M | – |
See a number that looks wrong?